← Back to all earnings calls

Serina Therapeutics, Inc. Q1 FY2022 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2022 Q1 Call date: 2022-05-13 Concluded

Share

Quarter scorecard

Revenue

$5,000

-91.1% YoY

Gross margin

80.0%

-14.6 pp YoY

Net income

$

Documents & deck